Des (N-(Methoxycarbonyl)) Velpatasvir
| Product Name | Des (N-(Methoxycarbonyl)) Velpatasvir |
|---|---|
| Alternate Names | Velpatasvir Impurities, Impurities of Velpatasvir |
| CAT No. | CS-O-15967 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | Not Available |
| Mol. For. | C47H52N8O6 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Velpatasvir |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | O=C(OC)N[C@H](C1=CC=CC=C1)C(N2[C@H](C3=NC=C(C4=CC5=C(C6=CC7=CC=C8C(NC([C@H]9N(C([C@H](C(C)C)N)=O)[C@@H](C)CC9)=N8)=C7C=C6OC5)C=C4)N3)C[C@H](COC)C2)=O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Des (N-(Methoxycarbonyl)) Velpatasvir is a highly effective antiviral medication that is used to treat chronic hepatitis C virus (HCV) infections in adults. It is a direct-acting antiviral agent that works by inhibiting the activity of the HCV NS5A protein, which is essential for viral replication. The medication is typically administered in combination with other antiviral agents, such as sofosbuvir, for maximum effectiveness.
Chemically, Des (N-(Methoxycarbonyl)) Velpatasvir is a synthetic derivative of velpatasvir, a potent NS5A inhibitor that has been extensively studied and shown to be highly effective in treating HCV infections. The addition of the methoxycarbonyl group to the molecule enhances its pharmacokinetic properties, making it more stable and better absorbed by the body.
In clinical trials, Des (N-(Methoxycarbonyl)) Velpatasvir has demonstrated excellent efficacy in treating HCV infections, with cure rates of up to 99%. It is generally well-tolerated, with few side effects reported. However, as with all medications, there is a risk of adverse reactions, and patients should be monitored closely while taking Des (N-(Methoxycarbonyl)) Velpatasvir.
Overall, Des (N-(Methoxycarbonyl)) Velpatasvir is an important new addition to the arsenal of antiviral medications used to treat HCV infections, and represents a significant advance in the treatment of this challenging disease.
Get an Instant Quote
Related Compounds
Velpatasvir Diastereomer 16 (D-valine Velpatasvir) | Des (N-(Methoxycarbonyl)-L-valine) Velpatasvir | VELPATASVIR D6 | Velpatasvir impurity 1 | Boc Velpatasvir intermediate R, R Isomer (Imidazole and Methoxy Methyl) | Boc Velpatasvir R, R, R Isomer (Imidazole, Methoxy Methyl and Methyl) | Velpatasvir R Isomer (Methoxy Methyl) | Velpatasvir Intermediate-I S,S-Isomer | Boc Velpatasvir Keto Impurity | Boc Velpatasvir R, R Isomer (Imidazole and Methoxy Methyl) | epi-Velpatasvir | Di Boc Velpatasvir impurity 1 | N-Nitroso Velpatasvir intermediate | Velpatasvir Diastereomer 1 (Velpatasvir R, R Isomer (Imidazole and Methoxy Methyl)) | Di Boc Velpatasvir Keto impurity 1 | Velpatasvir copovidone |